ISRG vs TSLA: Which Is the Better Buy?

Side-by-side comparison of Intuitive Surgical, Inc. and Tesla, Inc. โ€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-26.
Intuitive Surgical, Inc. ยท Healthcare
$399.52
+22.4% upside to fair value
Med Conviction Grade B High Quality
VS
Tesla, Inc. ยท Consumer Cyclical
$372.11
+45.0% upside to fair value
Med Conviction Grade C
QuantHub Verdict
TSLA has more upside to fair value (+45.0%). These are model outputs โ€” not personalized investment advice. See all research โ†’
Valuation & Fundamentals
Metric ISRG TSLA
Current Price $399.52 $372.11
Fair Value Estimate $488.97 $539.56
Upside to Fair Value +22.4% +45.0%
Market Cap $141.1B $1,469.7B
Forward P/E โ€” โ€”
EV / EBITDA 30.7x 121.7x
Price / Sales 12.8x 14.2x
Price / FCF 44.0x 209.1x
Revenue Growth YoY +18.5% +25.5%
Gross Margin 66.7% 18.9%
Operating Margin 31.3% 4.2%
Return on Equity 17.8% 4.6%
Dividend Yield 0% 0%
FCF Yield 2.28% 0.48%
Analyst Consensus Strong Buy Hold
Investment Thesis
ISRG โ€” Intuitive Surgical, Inc.
Intuitive Surgical develops, produces, and commercializes the da Vinci surgical system and the Ion endoluminal system, along with instruments, accessories, training, and digital solutions that drive a large installed-base and recurring-revenue model. Business quality is high: TTM gross margin of 66.7%, operating margin of 31.3%, net margin of 28.4%, ROE of 17.8%, and revenue growth of 18.5% with โ€ฆ
TSLA โ€” Tesla, Inc.
Tesla, Inc. designs, manufactures and sells electric vehicles and energy generation and storage systems, operating through Automotive and Energy Generation and Storage segments with 134,785 full-time employees and a market capitalization of $1,469.67 billion at a share price of $372.11. The business quality is mixed: revenue grew 25.5% year over year in the most recent quarter, but earnings fell โ€ฆ
Accumulation Zones
Metric ISRG TSLA
Zone Low $366.73 $404.67
Zone High $415.62 $458.63
In Buy Zone? Yes Yes
โ† ISRG Research    TSLA Research โ†’    All Research